Total visitors: 2,883 since 29-12-04
|
ISSN : 0301-1208 |
CODEN : IJBBBQ |
|
|
VOLUME 41 |
NUMBER 6 |
DECEMBER 2004 |
CONTENTS
|
Role of protein tyrosine kinase inhibitors in cancer therapeutics |
273 |
|
|
|
|
|
|
|
Papers |
|
|
Immunocontraceptive potential of recombinantly expressed minimized chicken riboflavin carrier protein (mini-RCP) in rodents |
|
|
Sarada Subramanian*, Anjali A Karande and P Radhakantha Adiga |
|
|
|
|
|
Partial purification, characterization and properties of two isoforms of glutamine synthetase from Pennisetum glaucum L. leaves |
|
|
|
|
|
|
|
|
cAMP-mediated upregulation of gelatinases in primary cultures of isolated rat hepatocytes |
|
|
|
|
|
|
|
|
Physico-chemical and antigenic characterization of unconventional heavy chain antibodies of Indian desert camel (Camelus dromedarius L.) |
|
|
|
|
|
|
|
|
A theoretical study of the stability of DNA binding with cis/trans platin |
305 |
|
Seema Srivastava, Irfan Ali Khan, Shinoo Srivastava and Vishwambhar Dayal Gupta* |
|
|
|
|
|
Phonon dispersion in polyinosinic acid |
311 |
|
Seema Srivastava, Shinoo Srivastava, Irfan Ali Khan, M K Pandey and V D Gupta* |
|
|
|
|
Notes |
|
|
Automated derivatization with o-phthalaldehyde
for estimation of amino acids in |
|
|
|
|
|
|
|
|
Determination of serum triglycerides using lipase, glycerol kinase, glycerol-3-phosphate oxidase and peroxidase co-immobilized onto alkylamine glass beads |
|
|
|
|
|
|
|
|
Inhibition of the hexokinase/hexose transporter region in the glycosomal membrane of bloodstream Trypanosoma brucei by oligomycin and digitonin |
|
|
Muturi R Njogu* and Job K Kiaira
|
|
Meeting Report (TRendys) |
333 |
|
|
|
Annual Author Index |
336 |
|
|
|
Annual Subject Index |
338 |
|
|
|
List of Referees |
351 |
|
|
|
Instructions to Authors |
354 |
|
|
|
*Author for correspondence
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 273-280
S B Bhise*, Abhijit D Nalawade and Hitesh Wadhawa
Protein tyrosine kinases (PTKs) are critical in regulating cell growth and differentiation and are deeply involved in several cancers. PTK-inhibitors are mainly ATP-site directed and are finding use in the treatment of several cancers, and more than 30 such agents are now in phase I-III clinical trials. The present review focuses mainly on the development of PTK inhibitors in clinical trials, with special emphasis on imatinib mesylate, a rationally designed, potent oral anticancer agent and selective inhibitor for Abl tyrosine kinase, including Bcr-Abl, C-kit and platelet-derived growth factor-receptor tyrosine kinases, which has been implicated in several malignancies, including chronic myeloid leukemia and gastro-intestinal stromal tumour.
Keywords: Protein tyrosine kinase, tyrosine kinase inhibitors, imatinib mesylate, chronic myeloid leukemia, acute myeloid leukemia, anticancer agent, gastrointestinal stromal tumor, epidermal growth factor receptor, vascular endothelial growth factor
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 281-287
Sarada Subramanian*,a, Anjali A Karandeb and P Radhakantha Adigac
Chicken riboflavin carrier protein (RCP; 219 AA) harbours four linear epitopes, constituted by the peptide residues 3-23, 64-83, 130-147 and 200-219. Antibodies to these sequences bioneutralize maternal RCP and provide protection from pregnancy in rodents. In order to overcome the major histocompatibility complex-dependent variability in immune response often encountered with use of single peptides for vaccination in genetically outbred populations, we have assembled a novel synthetic gene, incorporating in tandem the nucleotide sequences coding for all the four neutralizing epitopes of chicken RCP and expressed in Escherichia coli. The gene product, mini-RCP has been characterized for its immunogenic properties and contraceptive potential in rodents. Immunization of rabbits and rats led to generation of antibodies against individual peptide components, as determined by enzyme-linked-immunosorbent assay (ELISA). However, immunized rats carried pregnancy to term and delivered healthy offsprings. Antisera from these rats exhibited decreased affinity of binding to the native protein. These findings suggest that the prospects of covalently-linked epitope peptides need to be cautiously evaluated during the design and development of peptide-based vaccines.
Keywords: Immunocontraception, immunogenicity, chicken riboflavin carrier protein, major histocompatibility complex, minimized riboflavin carrier protein, synthetic gene, rat, rabbit
IPC Code: C12N 15/66, A61K 48/00
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 288-293
Shilpi Ghosh
Two isozymes of glutamine synthetase GS1 and GS2 were partially purified from Pennisetum glaucum leaves by ion-exchange and gel filtration chromatography and their kinetic and regulatory properties were studied using semisynthetase assay of GS. Mg2+ was the most effective cation for activity of both the isozymes; however, it could be efficiently replaced by Co2+. The pH optima for GS1 and GS2 were 7.0 and 8.0, respectively. GS1 exhibited maximum activity at 42°C, with activation energy of 18 KJ mol-1 and a Q10 of 3.0, whereas GS2 showed maximum activity at 50°C, with activation energy of 40 KJ mol-1 and Q10 of 2.25. GS1 was more thermostable than GS2. The Km value for Mg2+ of GS1 was 2-fold higher than GS2; however, these isozymes did not differ much in their affinity for other substrates. Alanine, serine and glycine lowered GS1 and GS2 activities, whereas cysteine enhanced their activities with a more pronounced effect on GS2. Serine inhibited the activity of both the isoforms in a competitive-manner, whereas alanine was a non-competitive inhibitor, with respect to glutamate. AMP and ADP were competitive inhibitor with respect to ATP for both the isozymes.
Keywords: Pennisetum glaucum leaves, glutamine synthetase, chloroplastic, cytosolic, isozymes.
IPC Code: C12N 9/00
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 294-298
K Saja and P R Sudhakaran*
Matrix metalloproteinases (MMPs) play a major role in tissue remodelling and repair in pathophysiological conditions, such as liver fibrosis and regeneration. Regulation of the MMPs produced by liver cells is important in maintaining cell-matrix ratio in liver, which is a major target site for hormones that mediate their intracellular effects through cAMP. The possibility of cAMP affecting the activity of MMPs and their endogenous inhibitors, tissue inhibitor of MMPs (TIMPs) was studied using isolated rat hepatocytes in culture. Zymographic analysis showed that treatment with hormones like epinephrine, thyroxine and dexamethasone and Bt2 cAMP increased 92 kDa MMP-9 activity. Bt2 cAMP caused upregulation of MMP-9 in a dose-dependent manner. The effect of hormones was less on MMP-2. ELISA using specific antibodies showed increase in levels of MMP-9 and TIMP-1 protein. Kinetic analysis of production of MMPs and TIMPs showed that the response to Bt2 cAMP was a delayed one, indicating its effect on de novo protein synthesis. These results suggest the possibility of cAMP dependent regulation of MMP-9 in the hepatocytes.
Keywords: Rat hepatocytes, matrix metalloproteinases (MMPs), tissue inhibitor of MMP (TIMP), cAMP-mediated upregulation, extracellular matrix (ECM), horse radish peroxidase.
IPC Code: C 12 Q 1/37
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 299-304
Sharvan Sehrawat and Ajit Singh*
Heavy chain antibodies (HCAbs) of IgG2 and IgG3 subtypes were purified from the sera of Indian desert camel (Camelus dromedarius L.) by ammonium sulphate precipitation, followed by ion-exchange chromatography on DEAE-cellulose and affinity chromatography on protein A-sepharose and protein G-sepharose, and characterized by SDS-polyacrylamide gel electrophoresis, agar gel immunodiffusion (AGID), counter-immunoelectrophoresis (CIEP), immunoelectrophoresis (IEP), ELISA and immunoblotting. IgG2 and IgG3 were found to have molecular mass 46.77 kDa and 43.65 kDa, respectively by SDS-PAGE under reducing conditions. They migrated in β-region in IEP and could be detected in CIEP, because of being more negatively charged and smaller size. Anti-camel IgG3 cross-reacted in AGID, ELISA and immunoblotting with IgGs of pig and ruminants (cattle, buffalo, sheep and goat), but not with immunoglobulins from horse, dog, guinea pigs, mice, fish, poultry and human. The present findings suggest close antigenic relationship of camels with pigs and ruminants.
Keywords: Indian camel, heavy chain antibodies, purification, electrophoresis, antigenic relationship, immunoblots, Camelus dromedarius L.
IPC Code: C 07 K 16/06
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 305-310
Seema Srivastava, Irfan Ali Khan, Shinoo Srivastava and Vishwambhar Dayal Gupta*
Both cis- and trans-platins are known to form intra- and interstrand cross-linking with DNA. Since the nature and strength of binding is different, it makes their efficacy as anti-tumour drug different. In the present communication, we report theoretical analysis by using an amended Zimm and Bragg theory, to explain the melting behaviour and heat capacity of DNA with and without platin binding. The sharpness of transition has been examined in terms of half width and sensitivity parameter (DH/s). The experimental measurements of Pilch et al (J Mol Biol 2000, 296, 803) and Ctirad and Brabec (J Biol Chem 2001, 276, 9655) have been used.
Keywords: cis/trans Platin, nucleation parameter, co-operativity, l-point anomaly, transition profile, DNA binding, heat capacity
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 311-321
Seema Srivastava, Shinoo Srivastava, Irfan Ali Khan, M K Pandey and V D Gupta*
A study of the normal modes of vibration and their dispersion in polyinosinic acid [poly (I)] along the helix axis based on Urey-Bradley force field is reported. It leads to a better interpretation of Raman and FTIR spectra. A comparison of dispersion curves of poly (I) with poly (G) has been made. Characteristic features of dispersion curves, such as regions of high density-of-states, repulsion and character mixing are discussed. Predictive value of heat capacity as a function of temperature is reported.
Keywords: Normal modes, dispersion curves, Fourier transform, density-of-states, polyinosinic acid
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 322-325
J V Gnanou*, S K Srinivas and A V Kurpad
A fully automated method for quantitative estimation of plasma amino acids using fluorescence detection of o-phthaladehyde/2-mercaptoethanol derivatives of the analytes and their separation by gradient elution reversed-phase HPLC has been described. The method is simple and the three-step gradient elution is suitable for routine analysis of a large number of biological samples due to clear resolution, high degree of precision, accuracy, cost-effectiveness and lack of interference from chemical contaminations. Using this method, 19 amino acids were completely resolved and the within-run coefficients of variation ranged from 2.53 to 10.7% with a mean variation of 5.68%.
Keywords: o-Phthaladehyde derivatization, reversed-phase high performance liquid chromatography, plasma amino acid analysis.
IPC Code: G01 N 33/88
Indian Journal of Biochemistry & Biophysics Vol.
41, December 2004, pp. 326-328
Vandana Kalia and Chandra S Pundir*
A method for determination of serum triglycerides (Tgs) using lipase, glycerol kinase, glycerol-3-phosphate oxidase and peroxidase co-immobilized onto alkylamine glass beads (pore diameter 55 nm) through glutaraldehyde coupling was developed and evaluated. The minimum detection limit of the method was 0.54 mM. The analytical recovery of added triolein in the serum was 97.55±1.5% (mean ± S.D.). The mean value of serum Tgs, determined by the present method showed a good correlation (r=0.984) with the Bayer’s kit method, employing free enzymes. The within and between batch coefficients of variation (CV) were <2.25% and <1.35% respectively. No significant loss of activity was observed, when co-immobilized enzymes were reused for about 200 times and stored at 4°C in distilled water. The cost of Tg determination for 200 serum samples was less, as compared with Bayer’s kit method.
Keywords: Triglyceride, lipase, glycerol kinase, glycerol-3-phosphate oxidase, peroxidase, co-immobilization, alkylamine glass, serum.
IPC Code: C12 Q 1/28, C12Q 1/61
Indian Journal of Biochemistry & Biophysics
Vol. 41, December 2004, pp. 329-332
Glycolysis in bloodstream T. brucei is the sole source of energy and remains a favourable chemotherapeutic target. In furtherance of this, an attempt has been made to understand better the contribution of glucose, fructose, mannose and glycerol to the energy charge of these parasites incubated in the presence of oligomycin, salicyhydroxamic acid (SHAM) and digitonin. Their cellular energy charge, when catabolizing glucose was 0.860, and under inhibition by oligomycin (10 mg), SHAM (2 mM) or oligomycin plus SHAM, 0.800, 0.444 and 0.405, respectively. Oligomycin inhibited the rate of catabolism of glucose, mannose and fructose up to 80%. The inhibition could not be alleviated by uncouplers, such as 2,4-dinitrophenol or permeabilization of the membranes by digitonin. Glucose-6-phosphate and other phosphorylated glycolytic intermediates, such as fructose-6-phosphate were catabolized by the permeabilized parasites in the presence of oligomycin, implying that except hexokinase, all the other glycolytic enzymes were active. Glucose oxidation was stimulated by low concentrations of digitonin (up to 4 mg), but at higher concentrations, it was significantly inhibited (up to 90% inhibition at 10 mg). Apparently, the inhibitory effects of oligomycin and digitonin were confined to glucose uptake and hexokinase catalysis. The above observations suggest that the hexose transporter and the enzyme hexokinase might be functionally-linked in the glycosomal membrane and oligomycin inhibits the linkage, by using a mechanism not linked to the energy charge of the cell. Digitonin at concentrations higher than 4 mg disrupted the membrane, rendering the complex in-operative. A hexokinase/hexose transporter complex in the glycosomal membrane is envisaged.
Keywords: Energy charge, glycosome, glycosomal membrane, hexokinase, hexose-transporter, oligomycin, salicyhydroxamic acid, digitonin, Trypanosoma brucei
|
281 |
305, 311 |
294 |
|||
|
|
|
329 |
299 |
||
|
273 |
322 |
299 |
|||
|
|
|
|
|
322 |
|
|
288 |
273 |
305, 311 |
|||
|
322 |
329 |
305, 311 |
|||
|
305, 311 |
311 |
281 |
|||
|
|
|
326 |
294 |
||
|
326 |
|
|
|
|
|
|
281 |
|
|
273 |
|
281 |
Jang Moon-Sun |
141 |
Pawar R |
254 |
|
|
Ahmad R |
148 |
Juneja M |
53 |
Phale P S |
227 |
|
Akdogan M |
57 |
|
|
Ponnuswamy M N |
184 |
|
Akgul C |
120 |
326 |
Porwal V |
34 |
|
|
Ali A M |
167 |
Kamat B P |
173 |
Prabhu Y |
227 |
|
Altintas L |
57 |
Kapoor H C |
29 |
Prasanna S |
179 |
|
An Sun-Young |
141 |
Karande A A |
281 |
Pundir C S |
102, 326 |
|
Annamalai P T |
40 |
Kaur K |
116, 221 |
Punekar N S |
205 |
|
Arif S H |
148 |
Kaya I |
120 |
|
|
|
Arunkumar N S |
96 |
305, 311 |
Rajasekar P |
188 |
|
|
|
|
Khan M M |
148 |
Ranhotra H S |
246 |
|
Bahadur A |
107 |
Khar A |
167 |
Rao J A |
241 |
|
Bahadur P |
107 |
329 |
Rath L S |
258 |
|
|
Banerjee S |
81 |
Kim Cheorl-Ho |
141 |
Raval M K |
258 |
|
Bansal D D |
20 |
Kim Ji-Youn |
141 |
Ray M |
7 |
|
Bansal M P |
14 |
Kole P L |
48 |
Ray S |
7 |
|
Basu A |
162 |
Krishnan S |
227 |
Reddy M |
167 |
|
Bhalla S |
116, 221 |
Kumari A L |
167 |
|
|
|
Bhatt P N |
123 |
Kumari M |
102 |
Sahindokuyucu F |
57 |
|
Bhattacharya I |
89 |
322 |
294 |
||
|
Bhattacharyya D |
162 |
|
|
Saraboji K |
184 |
|
Bhattacharyya Dhananjay |
233 |
Lakshmi V P |
205 |
Sawant M S |
216 |
|
Bhise S B |
273 |
Lee Young-Choon |
141 |
Seetharamappa J |
173 |
|
Bhowal J |
81 |
Lodha M L |
29 |
299 |
|
|
Bindu M P |
40 |
|
|
Sen P C |
162 |
|
Biswas S |
89 |
Mahmood A |
116, 221 |
Shalini S |
14 |
|
|
|
Mahmood S |
116, 221 |
Shanmukha I |
48 |
|
Cetinkaya O |
45 |
Majumdar R |
233 |
Sharma A |
154 |
|
Chandra A |
191 |
Manivannan E |
179 |
Sharma R |
246 |
|
Chatterjee M |
162 |
Manivasagam T |
188 |
Sharma S |
113 |
|
Chatterjee B P |
81 |
Mehra R |
53 |
Shi X |
216 |
|
Chaturvedi S C |
179 |
Mehta J P |
123 |
Sikdar S |
81 |
|
Cho Young-Su |
141 |
Melwanki M B |
173 |
Silig Y |
45 |
|
Choi Yong-Lark |
141 |
Mishra S |
254 |
299 |
|
|
|
|
Misra S N |
123 |
Sonawane S |
254 |
|
Das Hasi R |
89 |
Misra R M |
34 |
Sreedhar B |
250 |
|
Das R H |
89 |
Mitra A |
81 |
322 |
|
|
Dasgupta A K |
233 |
Mohankumar C |
96 |
305, 311 |
|
|
Demirezer L O |
45 |
Murugan K |
96 |
305, 311 |
|
|
Dutt, S |
23 |
Mwangi D W |
20 |
Subramanian P |
188 |
|
|
|
|
|
Subramanian S |
281 |
|
Eraslan G |
57 |
Nagappa A N |
48 |
294 |
|
|
Essiz D |
57 |
Nair K M |
250 |
Sun Y |
216 |
|
|
|
Nalawade A D |
273 |
|
|
|
Ghosh P K |
254 |
Nallini A |
184 |
Tandon P |
34 |
|
Ghosh S |
7 |
Neekhra N |
69 |
Tyagi A |
191 |
|
Ghosh Shilpi |
288 |
329 |
|
|
|
|
Ghosh Subho |
162 |
|
|
Varade D |
107 |
|
322 |
Ok Min |
141 |
Venkateswarlu K |
241 |
|
|
Guha A K |
81 |
|
|
Vethamuthu M S |
107 |
|
Gupta M N |
113 |
Padh H |
69 |
|
|
|
Gupta V D |
34, 305, 311 |
311 |
Wadhawa H |
273 |
|
|
|
|
Pandi P V |
48 |
|
|
|
Hasnain A |
148 |
Pang Q |
216 |
Yadav O P |
29 |
|
|
|
Pardhasaradhi B V V |
167 |
Yarsan E |
57 |
|
Jabeen M |
148 |
Patel A |
254 |
|
|
|
Jain S |
113 |
Patel V |
107 |
Zeeyauddin K |
48 |
|
Janave M T |
154 |
Pathak T V |
123 |
Zhang S |
216 |
|
|
|
Patil R T |
48 |
|
|
|
absorption, infrared |
34 |
Dioxygenase |
|
305 |
|
|
acetaminophen |
277 |
1-hydroxy-2-naphthoic acid |
227 |
Orbitals, Pseudo p |
184 |
|
Acetogenins |
167 |
ring-cleaving |
228 |
Oscillations, Circadian |
188 |
|
acetone |
328 |
dipole(s) |
179 |
osteoblastic |
57 |
|
acetosyringone |
206 |
atomic |
35 |
Over-expression |
102, 141, 211 |
|
acid(s) |
|
ion |
255 |
oxalate oxidase |
102 |
|
abscisic |
191 |
Dipyridyl, α,α- |
228 |
294 |
|
|
amino |
188 |
disease(s) |
|
326, 329 |
|
|
8-anilino-1-naphthalene sulphonic |
173 |
Hodgkins |
274 |
oxidative damage |
14 |
|
arachidonic |
246 |
Parkinson’s |
123 |
oxygenase, pheophorbide a |
154, 159 |
|
aromatic amino |
184 |
inflammatory |
20 |
oxyradicals |
43 |
|
ascorbic |
328 |
Dismutase, Superoxide |
20, 40 |
oxysterol |
14, 18 |
|
cis-4-(1-hydroxynaphth-2-yl)-2-oxobut-3-enoic |
231 |
disorders |
|
paclitaxel |
167 |
|
colominic |
81 |
gastro-intestinal |
53 |
paracetamol |
173 |
|
deoxyoctulosonic |
89 |
respiratory |
53 |
305 |
|
|
diaminetetraacetic |
143 |
Dispersion, Phonon |
34, 311 |
329 |
|
|
5,5-dithiobis-2-nitrobenzoic |
20 |
Distribution, Potential energy |
37 |
pathway(s) |
|
|
ethylene diamine tetraacetic |
20, 162 |
5,5′-dithiobis-(2-nitrobenzoic) |
7 |
biosynthetic-secretory |
70 |
|
ethylene glycol bis (b-amino |
|
dithiothreitol |
7 |
chlorophyll oxidase |
160 |
|
ethyl ether) N, N, N’, N’-tetraacetic |
162 |
DNA |
|
chlorophyllase |
158, 160 |
|
5-fluoroorotic |
205, 207 |
305 |
clathrin-mediated |
73 |
|
|
gallic |
21 |
305 |
1, 2-dihydroxynaphthalene |
227 |
|
|
gallotannic |
20 |
305 |
endocytic |
70, 74 |
|
|
1-hydroxy-2-naphthoic |
227 |
Docking |
76 |
endolysosomal |
71 |
|
lyso bis-phosphatidic |
69, 75 |
donor |
|
endosomal |
282 |
|
N-acetyl-neuraminic |
20 |
electronegative |
184 |
gentisate |
227 |
|
nalidixic |
48 |
proton |
184, 258 |
hydrophobic |
48 |
|
neuraminic |
20, 81 |
drug(s) |
|
lysosomal |
282 |
|
N-glycolylneuraminic |
20 |
305 |
non-clathrin-mediated |
73 |
|
|
311 |
anti-inflammatory |
179 |
o-phthalic acid |
227 |
|
|
oleic |
246 |
design |
275 |
phagocytic |
71 |
|
o-phthalic |
227 |
quinone |
45 |
signal transduction |
274 |
|
palmitic |
246 |
surface-active |
48 |
stimulicaspase-3-related |
167 |
|
perchloric |
330 |
D-tagatose |
81 |
Patients, Hypercholesterolemic |
15 |
|
311 |
D-talose |
81 |
Pennisetum glaucum |
288 |
|
|
311 |
Dye, Quinoneimine |
327 |
pepstatin A |
143 |
|
|
polyunsaturated fatty |
246 |
311 |
Peptide groups |
233 |
|
|
329 |
Dysmorphology, Craniofacial |
221 |
permeability |
48 |
|
|
saturated fatty |
246 |
Edema, Peripheral |
277 |
329 |
|
|
sialic |
81 |
eel |
148, 219 |
permeants |
48 |
|
tannic |
26 |
Effect(s) |
|
peroxidase |
|
|
thiobarbituric |
20 |
alcohol |
40 |
glutathione |
40 |
|
tricarboxylic |
14 |
antiulcerogenic |
45 |
294, 326 |
|
|
trichloroacetic |
89, 91, 162 |
circular dichroism cotton |
148 |
phenylalanine ammonia |
96 |
|
uric |
57, 328 |
pro-atherogenic |
14 |
peroxidation, lipid |
40 |
|
uronic |
89 |
Ehrlich ascites carcinoma |
7, 81 |
Peroxides, Lipid |
21 |
|
Acidogenesis |
212 |
299 |
Phagocytosis |
69 |
|
|
aconitase |
|
Electrophoresis |
|
phagosome |
69 |
|
duodenal cytosolic |
250 |
2-D polyacrylamide gel |
192 |
Phase, Hexadecane |
92 |
|
inhibition of duodenal cytosolic |
250 |
polyacrylamide gel |
29, 149, 216 |
phenanthrene |
227 |
|
Acrophase |
188 |
sodium dodecyl sulphate-poly |
|
1,10-phenanthroline |
227 |
|
actin |
217 |
acrylamide gel |
20, 81, 143, 299 |
Phenol, p-nitro |
164 |
|
activation |
|
electroporation |
206 |
Phenyl, Methyl sulfonyl fluoride |
14 |
|
hepatic GR |
246 |
Elements, Trace/toxic |
53 |
Phenylalanine, 3, 4-dihydroxy |
123 |
|
in vitro heat |
246 |
emodin |
46 |
322 |
|
|
inhibitors of GR heat |
246 |
Endocytosis |
69 |
322 |
|
|
receptor |
246 |
Endoplasmic, Reticulum |
26, 69 |
pheophorbide |
154 |
|
activator, plasminogen |
211 |
Endosomes |
69 |
pheophytin |
154 |
|
Activit(y)ies |
|
tubular |
74 |
Phosphatase(s) |
288 |
|
antimicrobial |
48,167 |
Endothapepsin |
237 |
alkaline |
221 |
|
alkaline phosphatase |
45, 57, 190 |
Energy, Activation |
255, 291 |
phosphate, |
|
|
anti-angiogenic |
276 |
Enterococcus faecalis |
120 |
cytidine mono |
20 |
|
antibacterial |
120 |
enterocytes |
119, 221 |
D-glyceraldehyde-3- |
7 |
|
antigen-degrading |
26 |
Enzyme |
|
329 |
|
|
anti-inflammatory |
45 |
antioxidant |
14, 20, 26, 40 |
orotidine-5’-mono |
205 |
|
anti-metabolite |
120 |
ATPase inhibitor of Na+, K+- |
162 |
p-nitrophenyl |
162 |
|
anti-microbial |
167 |
chlorophyll degrading |
154 |
Phosphokinase, tyrosine |
276 |
|
anti-neoplastic |
167 |
chloroplastic |
288 |
phospholipid |
49, 77 |
|
antipyretic |
45 |
cyclooxygenase-2 |
179 |
phosphoprotein |
288 |
|
anti-tumor |
167, 275, 305 |
digestive |
69 |
phosphorylase B |
217 |
|
caspase-3 |
167 |
drug-metabolizing |
45 |
phosphorylation |
162, 329 |
|
catalase |
22, 46 |
329 |
reversible |
288 |
|
|
chlorophyll-A degrading |
156 |
immobilized |
327 |
Photo-oxidation |
12 |
|
chlorophylloxidase |
158 |
inhibition of intracellular |
48 |
photorespiration |
288 |
|
cinnamyl alcohol-NADPH-dehydrogenase |
96 |
intestinal brush border |
221 |
photosynthesis |
159, 254, 292 |
|
cytosolic aconitase |
251 |
marker |
96 |
photosystem II |
159, 254, 258 |
|
cytotoxic |
167, 306 |
mycolytic |
206 |
Phthaladehyde, o- |
15, 168, 322 |
|
1-hydroxy-2-naphthoic acid dioxygenase |
227 |
proteolytic |
141 |
phycobilisomes |
254 |
|
DNase |
29 |
recombinant |
141 |
Phycocyanin, C- |
254 |
|
fucosyl transferase |
119 |
recovery |
102 |
phycoerythrin |
254 |
|
gelatinase |
295 |
ring-cleaving |
227 |
Phytohaemagglutinin |
283 |
|
glutathione peroxidase |
41 |
epinephrine |
296 |
Pinocytosis |
69 |
|
glutathione reductase |
22 |
erythrocytes |
241 |
Plaques, Atherosclerotic |
15 |
|
glutathione-S-transferase |
45 |
Estimation |
|
Plasmid (s) |
142, 206, 282 |
|
glycosyl transferases |
119 |
lipid peroxides |
21 |
305 |
|
|
hemagglutinating |
81 |
protein |
8 |
Plot, Sctachard |
85 |
|
hydroxylase |
20, 26 |
reduced glutathione |
22 |
pokeweed |
29 |
|
intracellular serine protease |
141 |
sialic acids |
22 |
Polyethylene |
37 |
|
lactase |
221 |
total thiols |
22 |
polyglycine I |
34 |
|
Mg-dechelatase |
157, 158 |
estrogen |
216 |
polymer |
312 |
|
microbicidal |
14, 26 |
Ethanol, b-Mercapto |
162 |
Polyporus squamosus |
81 |
|
N-glycosidase |
29 |
Ether, Octaethylene glycol mono-n-dodecyl |
162 |
311 |
|
|
parasiticidal |
167 |
322 |
polyvinyl polypyrrolidone |
29 |
|
|
pesticidal |
167 |
exocytosis |
70, 77 |
Porins |
48 |
|
photosynthetic |
292 |
exopolysaccharide |
89 |
Position, Planar |
233 |
|
p-nitrophenyl phosphatase |
163 |
exposure |
|
Powder, Acetone |
155 |
|
protocatechate-3, 4-dioxygenase |
231 |
cadmium |
53 |
299 |
|
|
radical scavenging |
254 |
electromagnetic field |
57 |
pregnancy |
221, 281 |
|
RNase |
29 |
ethanol |
116 |
primers |
142 |
|
semisynthetase |
293 |
lead |
53 |
hexamer |
169 |
|
sialyl transferase |
119 |
prenatal ethanol |
221 |
probe oxidation-sensitive fluorescent |
168 |
|
SOD |
22, 46 |
expression |
|
Probe(s) |
|
|
tumouricidal |
14 |
anachronistic |
209 |
hydrophobic |
173 |
|
Adaptins |
72 |
gene |
170, 191 |
cDNA |
169 |
|
adipocytes |
246 |
high-level |
141 |
Products, Phytylated |
160 |
|
adjuvant, Freund’s |
281 |
mini-RCP gene |
282 |
305, 309 |
|
|
agent (s) |
|
over- |
209, 274 |
Profile, Protein |
191 |
|
antibacterial |
48, 120 |
Extract, Seed |
167 |
Promoter(s) |
|
|
anticancer |
273 |
Factor(s) |
|
enolase |
211 |
|
antiseptic |
122 |
ADP ribosylation |
69 |
fungal |
209 |
|
bacterostatic |
48 |
epidermal growth |
69 |
properties |
|
|
reducing |
50 |
guanine nucleotide-exchange |
73 |
anti-bacterial |
48 |
|
sulfhydryl |
16 |
N-ethylmaleimide sensitive |
69 |
anticancer |
254 |
|
agglutinin (s) |
81 |
sexual agglutination |
85 |
anti-inflammatory |
254 |
|
dermatophyte |
86 |
steric |
238 |
antioxidant |
254 |
|
fungal |